The leader of a US private equity firm behind the creation of the UK’s Covid-19 rapid lateral flow tests has donated £50 million to his former university in Scotland.
Charles Huang’s gift to the University of Strathclyde in Glasgow is the largest it has received and one of the most generous made to a UK university.
Huang gained his MBA from Strathclyde in 1989 and his PhD in marketing in 1994.
In 2016 he founded Pasaca Capital Inc, a California-based private equity firm with a global focus on investing in innovative technologies and products.
Among its recent ventures is Innova Medical Group, which developed the rapid lateral flow tests used in Covid-19 testing programmes worldwide, including in the UK.
Huang, 57, made the donation
